Tivic Health Systems, Inc.
TIVC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 69.8% | 22.9% | -61.1% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | -$0 |
| % Margin | -99.3% | 62.8% | 71.4% | -132.8% |
| R&D Expenses | $1 | $1 | $0 | $0 |
| G&A Expenses | $0 | $1 | $1 | $1 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $2 | $2 | $1 |
| Operating Income | -$2 | -$2 | -$2 | -$2 |
| % Margin | -1,700.7% | -2,248.8% | -2,151.4% | -857.2% |
| Other Income/Exp. Net | -$0 | $0 | $0 | $0 |
| Pre-Tax Income | -$3 | -$2 | -$2 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3 | -$2 | -$2 | -$1 |
| % Margin | -1,778.1% | -2,245.3% | -2,145.7% | -820.6% |
| EPS | -1.97 | -2.19 | -2.52 | -3.2 |
| % Growth | 10% | 13.1% | 21.3% | – |
| EPS Diluted | -1.97 | -2.19 | -2.52 | -3.2 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 0 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$3 | -$2 | -$2 | -$1 |
| % Margin | -1,778.1% | -2,247.7% | -2,151.4% | -705.6% |